The cannabis market, long dormant, stirs from slumber, propelled by Germany’s legalization moves and the tantalizing prospect of U.S. marijuana rescheduling. Tim Seymour of Seymour Asset Management, speaking on Benzinga’s PreMarket Prep, delved into the unfolding drama of what he termed “exciting times” in the cannabis domain.
Regulatory Ripples: Germany’s recent law adjustments sparked a rally in weed equities. Effective April 1, Germany will erase cannabis from its Narcotics Act, where it had been ensnared as a banned substance under punitive regulations.
“Germany has silently outpaced the U.S. They may leapfrog us to full federal legalization for the adult market,” Seymour remarked during the show.
Key Event: Catch Tim Seymour at the Benzinga Cannabis Capital Conference in Hollywood, Florida, on April 16-17. Snag your tickets now before prices soar. A 20% discount is yours by clicking the link posthaste.
Seymour pinpointed Tilray Brands, Inc. (TLRY) as Europe’s premier distributor, primed to capitalize on Germany’s fresh statutes. Tilray’s astute investments in Germany of yore could now yield hefty returns in the new cannabis regulatory framework, Seymour noted.
The Big Picture: Investors in the cannabis sphere view Germany’s progressive strides as a harbinger of brighter days for the industry, foretelling swelling sales and revenue upticks. Many harbor hopes that the U.S. might emulate Germany’s lead with federal rescheduling and potential decriminalization.
In Related Developments: Canopy Growth’s CEO Predicts German Cannabis Market Could Expand tenfold Post-Legalization
Seymour underlined the mushrooming tally of states legalizing medical and recreational cannabis. He deems U.S. rescheduling as an inescapable denouement and indicated that the Biden Administration is fast running out of time before the next election.
“The writing is on the wall, the outcome inevitable,” Seymour emphatically stated.
Vice President Kamala Harris pressed the DEA to expedite marijuana rescheduling during a recent White House forum.
“Labeling marijuana as dangerous as heroin and more hazardous than fentanyl is ludicrous, not to mention egregiously lopsided,” Harris remarked during the deliberations.
Seymour foresees an amplifier in cannabis sector growth, fueled by sweeping operational enhancements and impending industry stimuli.
“Those planting seeds now are sure to reap a rich harvest,” Seymour asserted.
TLRY Price Snapshot: Per Benzinga Pro data, Tilray stocks had climbed 0.92% to $2.50 at the time of publishing.
Image: asdqwejkl from Pixabay
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
